MedPath

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Not yet recruiting
Conditions
Pulmonary Fibrosis
Registration Number
NCT05899556
Lead Sponsor
Power Life Sciences Inc.
Brief Summary

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patient is at least 18 years of age
  • Diagnosis of pulmonary fibrosis
  • Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
Exclusion Criteria
  • Enrolled in another research study
  • Inability to provide written informed consent
  • Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of pulmonary fibrosis patients who decide to participate in a clinical study3 months
Rate of patients who remain in an pulmonary fibrosis clinical study to completion12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Power Life Sciences

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath